vimarsana.com
  1. Home
  2. Live Updates
  3. Dermavant Sciences Gmbh - Breaking News

Latest Breaking News On - Dermavant sciences gmbh - Page 1 : vimarsana.com

Torii Pharmaceutical : Positive Top line Results of Phase 3 Clinical Study (Comparative Study) of JTE 061 (tapinarof) Cream, Aryl hydrocarbon Receptor (AhR) agonist, in Pediatric Patients with Atopic Dermatitis in Japan

FOR IMMEDIATE RELEASE Tokyo, May 31, 2024 Positive Top-line Results of Phase 3 Clinical Study of JTE-061 Cream, Aryl hydrocarbon Receptor .

Japan tobacco incDermavant sciences gmbhTorii pharmaceutical co ltdTop line resultsComparative studyPediatric patientsAtopic dermatitisEczema areaSeverity index

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.